What are the percentages of the testosterone fractions (free, albumin-bound, and SHBG-bound) in adult males?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Porcentaje de Fracciones de Testosterona en Hombres Adultos

En hombres adultos, solo el 0.5-3% de la testosterona circulante está libre (no unida), aproximadamente 40-55% está unida a albúmina, y aproximadamente 43-62% está unida a SHBG (globulina fijadora de hormonas sexuales). 1, 2, 1

Distribución de las Fracciones

Las guías de la Endocrine Society establecen claramente que:

  • Testosterona libre: 0.5-3% del total
  • Testosterona unida a albúmina: Aproximadamente 40-55%
  • Testosterona unida a SHBG: Aproximadamente 43-62%

La mayoría de la testosterona circulante está unida a proteínas, siendo SHBG y albúmina las principales proteínas transportadoras 1.

Concepto de Testosterona Biodisponible

La testosterona "biodisponible" incluye tanto la fracción libre como la unida a albúmina, representando aproximadamente 45-58% del total. Esta definición se basa en la hipótesis de que la testosterona unida a albúmina se disocia fácilmente y está disponible para los tejidos, a diferencia de la fracción unida a SHBG que está fuertemente ligada 1.

Variabilidad Según Condiciones Clínicas

Los porcentajes de estas fracciones no son constantes y varían significativamente según:

  • Edad: Los hombres mayores tienden a tener niveles más altos de SHBG, lo que reduce la fracción libre
  • Obesidad: Disminuye SHBG, aumentando proporcionalmente la testosterona libre
  • Diabetes mellitus: Reduce SHBG
  • Enfermedades tiroideas: Alteran significativamente los niveles de SHBG
  • Medicamentos: Opioides, glucocorticoides y otros fármacos modifican la distribución

1

Implicaciones Clínicas Importantes

La medición de testosterona total puede ser engañosa cuando hay alteraciones en SHBG. En estas situaciones, es esencial medir o calcular la testosterona libre o biodisponible para evaluar correctamente el estado androgénico del paciente 1.

Advertencias Críticas:

  • No utilizar métodos de inmunoensayo directo para testosterona libre, ya que son extraordinariamente inexactos 3, 1
  • La testosterona libre debe medirse por diálisis de equilibrio o calcularse a partir de testosterona total, SHBG y albúmina 1
  • Los valores calculados dependen críticamente de la calidad de los ensayos de testosterona total y SHBG 1

Datos de Investigación Complementarios

Estudios más recientes confirman que la fracción libre de testosterona en hombres normales es aproximadamente 2.0% del total, con 53-55% unida a albúmina y 43-45% unida a SHBG 4. Durante la terapia de reemplazo con testosterona, estos porcentajes pueden modificarse de manera no lineal por cambios en las concentraciones de testosterona, dihidrotestosterona y estradiol 5.

Related Questions

How should I evaluate and manage a 44‑year‑old woman with low free testosterone and low bioavailable testosterone, but normal total testosterone, sex hormone‑binding globulin (SHBG), follicle‑stimulating hormone (FSH), and luteinizing hormone (LH)?
A 49-year-old man with a history of hypogonadism has an initial total testosterone of 289 ng/dL, a repeat total testosterone of 333 ng/dL, and a free testosterone of 67 pg/mL. Does he qualify for testosterone replacement therapy?
In a 75-year-old man receiving testosterone replacement therapy (200 mg testosterone enanthate every two weeks) with free testosterone 203 pg/mL, total testosterone 889 ng/dL, and estradiol 43 pg/mL, what further workup and treatment adjustments are recommended?
Can elevated estradiol from aromatization of testosterone replacement therapy be the cause of his symptoms such as gynecomastia, mood changes, decreased libido, or fluid retention?
In a 43-year-old woman with progesterone <0.5 ng/mL, estradiol <30 pg/mL, luteinizing hormone ≈12 IU/L, follicle‑stimulating hormone ≈9 IU/L, total testosterone 23 ng/dL, free testosterone 2.9 pg/mL, and sex hormone‑binding globulin 82 nmol/L, what is the most likely diagnosis and what is the appropriate first‑line management?
In a patient who has not responded adequately to rifaximin alone, should neomycin be added to the treatment regimen?
Is acute contrast-induced sialadenitis associated with HIV infection?
How should rifaximin (Xifaxan) 550 mg three times daily be used together with neomycin to treat hydrogen‑predominant small intestinal bacterial overgrowth (SIBO)?
If rifaximin (Xifaxan) is not an option for hydrogen‑predominant small intestinal bacterial overgrowth (SIBO), what alternative antibiotics and their dosages can be used?
What are the anesthetic considerations and concerns for a patient with limb‑girdle muscular dystrophy?
In a 63-year-old non‑smoking man with a 2‑year history of daily productive cough, remote cotton‑dust exposure, stable vital signs, and rhonchi on examination, what is the most likely diagnosis: asthma, chronic obstructive pulmonary disease (COPD), chronic eosinophilic pneumonia, or chronic aspergillosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.